SEBI grants NOC for NSE IPO, likely to file DRHP by April
SEBI grants NOC for NSE IPO, ending decade-long delays over co-location case. NSE, led by Ashishkumar Chauhan, may list in 8–9 months and is valued at nearly ₹5 lakh crore.
Uncategorized
Northern Arc Capital posts record Q3 profit; lending AUM crosses ₹15,000 crore milestone
Northern Arc Capital posted record quarterly profit of ₹101 crore and crossed ₹15,000 crore in lending AUM, driven by D2C growth. Shares of Northern Arc Capital ended higher on Friday, January 30, by 3.01% at ₹272.01 on the NSE.
Harish Krishnan says markets are in reset mode, urges investors to look beyond market caps
Harish Krishnan, CIO – Equity, Aditya Birla Sun Life AMC, does not expect major surprises in the Union Budget and believes continued focus on capital expenditure would be positive. He also sees scope for measures to boost consumption, while changes…
Money rushes into emerging markets at record levels despite firm dollar
Global Liquidity Tracker shows GEM fund inflows hit $11 billion as de-dollarisation trade intensifies, while DXY stays range-bound. India and commodity funds see record inflows despite mixed trends.
Blue Dart Q3 profit dips on one-time charge, revenue up 7%, margins rise
Blue Dart Express Q3 net profit drops 15.7% to ₹68.3 crore as revenue rises, driven by tier II and III markets and strong operational discipline. Shares of Blue Dart Express ended higher today, January 30, by 1.90% at ₹5,515 on…
MedPlus Health Q3 net profit surges 26% on higher sales and new stores
MedPlus Health Services posted a 26.2% YoY rise in Q3 net profit to ₹57.8 crore on revenue growth of 15.7% to ₹1,806 crore. EBITDA increased 19.7% to ₹158.5 crore, with margins improving marginally to 8.78%. The company added 182 stores…
American Express Q4 EPS misses estimates despite 10% revenue growth
Provision for credit losses increased 7.7% year-on-year to $1.4 billion, compared with estimates of $1.45 billion, while total expenses rose to $14.5 billion, higher than the Street estimate of $14.22 billion.
Subros Q3 profit rises 5% to ₹34.7 crore despite margin squeeze
Revenue from operations grew 15.4% YoY to ₹947.6 crore, compared with ₹820.9 crore in the year-ago period, aided by steady demand from OEM customers.
Glenmark Pharma Q3: Profit, revenue up over 15% as India, North America drive growth
Glenmark Pharmaceuticals posted strong Q3 results with profit and revenue rising over 15% YoY, aided by robust growth in India and North America and sharp operating margin expansion.
SAIL Q3 net profit zooms nearly 3x on higher volumes, beats forecast
SAIL reported a Q3 net profit of ₹374 crore, up from ₹142 crore YoY and slightly above the CNBC-TV18 poll of ₹370 crore. Revenue grew 12% YoY to ₹27,371 crore, while EBITDA rose 13% to ₹2,294 crore with margins improving…